Streetbeat News

YOURF

YourWay Cannabis Brands Inc

Industry

Pharmaceutical Preparation Manufacturing

Open

0.00

Mkt cap

18M

Volume

4.2K

High

0.00

P/E Ratio

N/A

52-wk high

0.00

Low

0.00

Div yield

N/A

52-wk low

0.00

YourWay Cannabis Brands Inc. has terminated the agreement to sell Labtronix, Inc. after a surprise fire department inspection led to a cessation of Labtronix's operations. Shareholders were against the $3M sale, considering it below fair market value. A special meeting to vote on the sale was canceled. Carl Saling III, a significant shareholder, opposed the sale and nominated new directors. Trulieve Cannabis Corp. filed a complaint against YourWay Cannabis and others for alleged kickback schemes.

Portfolio Pulse from Jelena Martinovic

December 06, 2023 | 1:37 pm

YourWay Cannabis Brands Inc. has agreed to sell Labtronix, Inc. for $3 million, structured as a secured note. The sale will relieve YourWay of all lawsuits, liabilities, and tax liabilities related to Labtronix. Shareholder Carl Saling III, holding 11% of YourWay's shares, has nominated six directors to the board, expressing concern over the company's direction and the asset sale's terms. Saling aims to halt the sale, complete an audit, and restore trading status. Trulieve Cannabis Corp. previously filed a complaint against YourWay and Labtronix for alleged kickback schemes.

Portfolio Pulse from Jelena Martinovic

December 01, 2023 | 6:46 pm

YourWay Cannabis Brands Inc. has confirmed receipt of a complaint filed by Trulieve Cannabis Corp., Harvest Health & Recreation, and Randy Taylor Consulting. The complaint alleges that YourWay, among others, participated in unlawful kickback schemes to the detriment of the plaintiffs. The alleged misconduct occurred prior to the tenure of the current management team. YourWay is investigating the claims and will provide further updates once a course of action has been authorized by the board of directors.

Portfolio Pulse from Nina Zdinjak

October 09, 2023 | 1:19 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.